99 related articles for article (PubMed ID: 21966778)
1. [Hormone therapy effect in postmenopausal women with history of endometrial cancer].
Arteaga-Gómez AC; Castellanos-Barroso G; Colin-Valenzuela A; García-Vargas J; Márquez-Acosta G; Reyes-Muñoz E
Ginecol Obstet Mex; 2011 Jan; 79(1):11-7. PubMed ID: 21966778
[TBL] [Abstract][Full Text] [Related]
2. [Conservative treatment of endometrial cancer as a way to preserve fertility. Five-year experience at Instituto Nacional de Perinatilogía Isidro Espinoza de los Reyes].
Arteaga Gómez AC; Castellanos Barroso G; Márquez Acosta G
Ginecol Obstet Mex; 2012 Jun; 80(6):394-9. PubMed ID: 22826967
[TBL] [Abstract][Full Text] [Related]
3. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769
[TBL] [Abstract][Full Text] [Related]
4. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.
Barakat RR; Bundy BN; Spirtos NM; Bell J; Mannel RS;
J Clin Oncol; 2006 Feb; 24(4):587-92. PubMed ID: 16446331
[TBL] [Abstract][Full Text] [Related]
5. Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy.
Perez-Medina T; Bajo-Arenas J; Haya J; Sanfrutos L; Iniesta S; Bueno B; Castelo-Branco C
Menopause; 2003; 10(6):534-7. PubMed ID: 14627862
[TBL] [Abstract][Full Text] [Related]
6. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
7. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
[TBL] [Abstract][Full Text] [Related]
8. [Endometrial carcinoma. The experience of the Hospital San Juan de Dios].
Saavedra R; Saavedra F; Muster H
Rev Chil Obstet Ginecol; 1992; 57(6):424-31. PubMed ID: 1364568
[TBL] [Abstract][Full Text] [Related]
9. [Hormone therapy and risk for breast cancer in Finnish postmenopausal women].
Lyytinen H; Ylikorkala O
Duodecim; 2011; 127(3):235-42. PubMed ID: 21438346
[TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer--surprising reports.
Speroff L
Maturitas; 2005 Aug; 51(4):329-33. PubMed ID: 16039404
[No Abstract] [Full Text] [Related]
11. The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma.
Jutzi L; Hoskins P; Lim P; Aquino-Parsons C; Tinker A; Kwon JS
Gynecol Oncol; 2013 Dec; 131(3):581-5. PubMed ID: 24055614
[TBL] [Abstract][Full Text] [Related]
12. Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials.
Biglia N; Maffei S; Lello S; Nappi RE
Gynecol Endocrinol; 2010 Nov; 26(11):804-14. PubMed ID: 20586550
[TBL] [Abstract][Full Text] [Related]
13. [Multivariate analysis of prognostic factors in endometrial carcinoma].
Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
[TBL] [Abstract][Full Text] [Related]
14. Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition.
Allen NE; Tsilidis KK; Key TJ; Dossus L; Kaaks R; Lund E; Bakken K; Gavrilyuk O; Overvad K; Tjønneland A; Olsen A; Fournier A; Fabre A; Clavel-Chapelon F; Chabbert-Buffet N; Sacerdote C; Krogh V; Bendinelli B; Tumino R; Panico S; Bergmann M; Schuetze M; van Duijnhoven FJ; Bueno-de-Mesquita HB; Onland-Moret NC; van Gils CH; Amiano P; Barricarte A; Chirlaque MD; Molina-Montes ME; Redondo ML; Duell EJ; Khaw KT; Wareham N; Rinaldi S; Fedirko V; Mouw T; Michaud DS; Riboli E
Am J Epidemiol; 2010 Dec; 172(12):1394-403. PubMed ID: 20961969
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy in women with past history of endometriosis.
Soliman NF; Hillard TC
Climacteric; 2006 Oct; 9(5):325-35. PubMed ID: 17000581
[TBL] [Abstract][Full Text] [Related]
16. Endometrial adenocarcinoma after prolonged tibolone therapy.
Nassar AH; Khalil AM; Seoud MA; Usta IM
Int J Gynaecol Obstet; 2005 Jul; 90(1):78-9. PubMed ID: 15913616
[No Abstract] [Full Text] [Related]
17. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K
Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
[TBL] [Abstract][Full Text] [Related]
18. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
[TBL] [Abstract][Full Text] [Related]
19. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
[TBL] [Abstract][Full Text] [Related]
20. The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer.
Lachance JA; Everett EN; Greer B; Mandel L; Swisher E; Tamimi H; Goff B
Gynecol Oncol; 2006 Jun; 101(3):470-5. PubMed ID: 16413048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
